Moleculin Biotech, Inc. Completes NASDAQ Initial Public Offering
Go back to Moleculin Biotech, Inc. Completes NASDAQ Initial Public Offering| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 2.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.75 | 52 Week High | $9.58 | |||
| Open | $2.75 | 52 Week Low | $2.34 | |||
| Day High | $2.75 | P/E | N/A | |||
| Day Low | $2.75 | EPS | $-0.34 | |||
| Volume | 111,281 | |||||
